Aradhana  Sarin net worth and biography

Aradhana Sarin Biography and Net Worth

CFO & Exec. Director of AstraZeneca
Prior to her current role, Aradhana was CFO for Alexion. Aradhana joined Alexion in 2017 and was responsible for driving strategic growth, financial performance and business development at Alexion. She brings operational experience in biopharma plus more than 20 years of professional experience at global financial institutions and has extensive knowledge of global healthcare systems, having closed more than 100 transactions across M&A, equity and debt financing. Before joining Alexion, Aradhana was Managing Director of Healthcare Corporate and Investment Banking at Citi Global Banking, focusing on clients in the life sciences and biopharmaceutical sectors. Previously, she served as Managing Director of Healthcare Investment Banking at UBS, and worked at JP Morgan in the M&A Advisory and Healthcare groups. Aradhana trained as a medical doctor in India and spent two years practising in both India and Africa. She completed her medical training at the University of Delhi and received her MBA from Stanford Business School.

How old is Aradhana Sarin?

Dr. Sarin is currently 50 years old. There are 3 older executives and no younger executives at AstraZeneca. The oldest executive at AstraZeneca is Mr. Pascal Soriot D.V.M., M.B.A., CEO & Executive Director, who is 65 years old. Learn More on Aradhana Sarin's age.

How do I contact Aradhana Sarin?

The corporate mailing address for Dr. Sarin and other AstraZeneca executives is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. AstraZeneca can also be reached via phone at 442037495000 and via email at [email protected]. Learn More on Aradhana Sarin's contact information.

Has Aradhana Sarin been buying or selling shares of AstraZeneca?

Aradhana Sarin has not been actively trading shares of AstraZeneca over the course of the past ninety days. Learn More on Aradhana Sarin's trading history.

Who are AstraZeneca's active insiders?

AstraZeneca's insider roster includes Katarina Ageborg (EVP of Sustainability), Pam Cheng (EVP of Operations & Information Technology and Member of External Sustainability Advisory Board ), Marc Dunoyer (CEO of Alexion & Chief Strategy Officer ), Menelas Pangalos (EVP ), Aradhana Sarin (CFO & Exec. Director ), and Pascal Soriot (Executive Director and Chief Executive Officer ). Learn More on AstraZeneca's active insiders.

Aradhana Sarin Insider Trading History at AstraZeneca

See Full Table

Aradhana Sarin Buying and Selling Activity at AstraZeneca

This chart shows Dr. Aradhana Sarin M.D.'s buying and selling at AstraZeneca by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AstraZeneca Company Overview

AstraZeneca logo
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More

Today's Range

Now: $63.20
Low: $62.88
High: $63.93

50 Day Range

MA: $73.99
Low: $63.20
High: $79.58

2 Week Range

Now: $63.20
Low: $60.47
High: $87.68

Volume

7,047,699 shs

Average Volume

7,884,636 shs

Market Capitalization

$195.96 billion

P/E Ratio

30.24

Dividend Yield

1.54%

Beta

0.47